Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q37462542)
Watch
English
Indications for therapy in hepatitis B.
scientific article published on May 2009
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
19399799
retrieved
20 August 2017
title
Indications for therapy in hepatitis B.
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
19399799
retrieved
20 August 2017
author name string
Bulent Degertekin
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
19399799
retrieved
20 August 2017
Anna S F Lok
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
19399799
retrieved
20 August 2017
language of work or name
English
0 references
publication date
1 May 2009
1 reference
stated in
Europe PubMed Central
PubMed ID
19399799
retrieved
20 August 2017
published in
Hepatology
1 reference
stated in
Europe PubMed Central
PubMed ID
19399799
retrieved
20 August 2017
volume
49
1 reference
stated in
Europe PubMed Central
PubMed ID
19399799
retrieved
20 August 2017
issue
5 Suppl
1 reference
stated in
Europe PubMed Central
PubMed ID
19399799
retrieved
20 August 2017
page(s)
S129-37
1 reference
stated in
Europe PubMed Central
PubMed ID
19399799
retrieved
20 August 2017
cites work
Chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22931
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22931
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized controlled trial of lamivudine to treat acute hepatitis B
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22931
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22931
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Determinants of early mortality in patients with decompensated chronic hepatitis B treated with antiviral therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22931
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: a comparative study using a matched, untreated cohort
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22931
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lamivudine treatment in patients with severely decompensated cirrhosis due to replicating hepatitis B infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22931
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatitis flares and hepatitis B e antigen seroconversion: implication in anti-hepatitis B virus therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22931
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The role of lamivudine and predictors of mortality in severe flare-up of chronic hepatitis B with jaundice.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22931
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The effect of lamivudine therapy in hepatic decompensation during acute exacerbation of chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22931
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Interferon-alpha for HBeAg-positive chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22931
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical outcome of HBeAg-negative chronic hepatitis B in relation to virological response to lamivudine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22931
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Outcome of hepatitis B e antigen-negative chronic hepatitis B on long-term nucleos(t)ide analog therapy starting with lamivudine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22931
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lamivudine for patients with chronic hepatitis B and advanced liver disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22931
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22931
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Predicting cirrhosis risk based on the level of circulating hepatitis B viral load
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22931
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22931
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Risk and predictors of mortality associated with chronic hepatitis B infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22931
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Predictors of HBeAg loss after lamivudine treatment for chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22931
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Telbivudine versus lamivudine in patients with chronic hepatitis B
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22931
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22931
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22931
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatitis B e antigen and the risk of hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22931
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22931
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatitis B viremia is associated with increased risk of hepatocellular carcinoma in chronic carriers
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22931
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The relationship between HBV-DNA levels and cirrhosis-related complications in Chinese with chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22931
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22931
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The clinical significance of persistently normal ALT in chronic hepatitis B infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22931
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22931
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chronic hepatitis B virus carriers in the immunotolerant phase of infection: histologic findings and outcome
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22931
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22931
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22931
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22931
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Natural history of chronic HBV carriers in northern Italy: morbidity and mortality after 30 years.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22931
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term outcome of chronic hepatitis B in Caucasian patients: mortality after 25 years
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22931
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22931
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment recommendations for chronic hepatitis B: an evaluation of current guidelines based on a natural history study in the United States
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22931
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22931
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in health care workers (HCWs): guidelines for prevention of transmission of HBV and HCV from HCW to patients.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22931
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prolonged antiviral therapy for hepatitis B virus-infected health care workers: a feasible option to prevent work restriction without jeopardizing patient safety
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22931
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1002/HEP.22931
1 reference
stated in
Europe PubMed Central
PubMed ID
19399799
retrieved
20 August 2017
PubMed ID
19399799
1 reference
stated in
Europe PubMed Central
PubMed ID
19399799
retrieved
20 August 2017
ResearchGate publication ID
24366795
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
